Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Bio Path Holdings Inc

BPTH
Current price
0.52 USD -0.0023 USD (-0.44%)
Last closed 0.54 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 7 008 921 USD
Yield for 12 month -64.59 %
Week
Month
Year
BPTH
21.11.2021 - 28.11.2021

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 (BP1002) for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 (BP1003) for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and BP1001-A for the treatment of solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas. Address: 4710 Bellaire Boulevard, Bellaire, TX, United States, 77401

Analytics

WallStreet Target Price

12 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures BPTH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -16 707 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -89.11 %
PEG Ratio
Return On Equity TTM -178.1 %
Wall Street Target Price 12 USD
Revenue TTM
Book Value 0.22 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -2 USD
Diluted Eps TTM -2 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BPTH

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BPTH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 18.01.2019
Dividend Date 18.01.2019

Stock Valuation BPTH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.2888
Price Book MRQ 2.7758

Financials BPTH

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators BPTH

For 52 weeks

0.32 USD 2.35 USD
50 Day MA 0.52 USD
Shares Short Prior Month 969 631
200 Day MA 1.07 USD
Short Ratio 0.74
Shares Short 695 646
Short Percent 5.65 %